Isabelle Karine da Costa Nunes

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências Matemáticas e da Natureza

Unidade:

Instituto de Química

Departamento:

Seção de Atividades Gerenciais IQ/CCMN

ORCID:

não disponível no Lattes


Formação:
  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 2013 - 2016
  • Universidade Federal do Rio de Janeiro

    Farmacologia e Química Medicinal | Doutorado | 2009 - 2013
  • Universidade Federal de Alagoas

    Química e Biotecnologia | Mestrado | 2006 - 2008
  • Universidade Federal de Alagoas

    Farmacia Hospitalar | Especialização | 2005 - 2006
  • Universidade Federal de Alagoas

    Farmácia | Graduação | 2000 - 2003
  • Centro Federal de Educação Tecnológica de Alagoas

    | Ensino Profissional de nível técnico | 1999 - 2000
  • Colégio Rosa Mística

    | Ensino Médio (2o grau) | 1995 - 1997
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(100.00% artigos com DOI)

Titulo DOI Ano
In vitro and in vivo antiplasmodial activity of novel quinoline derivative compounds by molecular hybridization 10.1016/j.ejmech.2021.113271 2021
Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: In vitro and in vivo preclinical studies 10.1016/j.ejmech.2020.112492 2020
Comprehensive Zebrafish Water Tank Experiment for Metabolic Studies of Testolactone 10.1089/zeb.2019.1791 2020
Development of a liquid chromatography Q Exactive high resolution mass spectrometry method by the Box-Behnken design for the investigation of sibutramine urinary metabolites 10.1016/j.jchromb.2019.121726 2019
The black market for anorectic agents: A case study of amfepramone 10.1016/j.toxac.2018.03.001 2018
Zebrafish ( Danio rerio ) water tank model for the investigation of drug metabolism: Progress, outlook, and challenges 10.1002/dta.2523 2018
Synthesis, solubility, plasma stability, and pharmacological evaluation of novel sulfonylhydrazones designed as anti-diabetic agents 10.2147/DDDT.S108327 2016
Synthesis, Pharmacological Profile and Docking Studies of New Sulfonamides Designed as Phosphodiesterase-4 Inhibitors 10.1371/journal.pone.0162895 2016
The Importance of Metabolism Study in the Early Stages of Drugs Development 10.5935/1984-6835.20150028 2015
In Vitro Microsomal Hepatic Metabolism of Antiasthmatic Prototype LASSBio-448 10.2174/1568026614666140506123718 2014
Benzenesulfonamide attenuates monocrotaline-induced pulmonary arterial hypertension in a rat model 10.1016/j.ejphar.2012.05.043 2012
Quinonoid and phenazine compounds: Synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis 10.1016/j.ejmech.2011.07.026 2011
14b-Chloro-4a-methoxy-3,3-dimethyl-2,3,4a,14b-tetrahydro-1H-benzo[a]-pyrano[2,3-c]phenazine: a new activestructural type against Mycobacterium tuberculosis. 10.1107/S1600536807033259 2007
Eventos:
Nenhum evento cadastrado
Publicações:
Minha Rede: